
Cannabis affects the body because its bioactive compounds bind to and activate tiny receptors encoded by our genes.
The brain and nervous system contain a different set of receptors (CB1) than the receptors used primarily in our immune system/inflammation (CB2).
Because CB2 activation dampens inflammatory responses, it has the potential to serve as a molecular target for diminishing inflammation linked to pathogenic disorders such as MS, ischemic/perfusion injury following an induced stroke, rheumatoid arthritis, inflammatory bowel disease and osteoporosis pain. (Centonze et. al 2007) .
Neuroinflammation is key to both autoimmune disorders (multiple sclerosis, lupus, psoriasis, etc) and Neurodegenerative diseases (Alzheimer’s, Parkinson’s, Huntington’s, etc) (Wolf Tauber, and Ullrich 2008; Pryce, Jackson and Baker 2008).
Disclaimer: not medical advice. These products are not approved by the FDA to treat, diagnose, or cure any disease.